LFCR
Price
$7.43
Change
+$0.08 (+1.09%)
Updated
Jul 25 closing price
Capitalization
176.87M
31 days until earnings call
SBFM
Price
$1.57
Change
+$0.02 (+1.29%)
Updated
Jul 25 closing price
Capitalization
6.02M
3 days until earnings call
Interact to see
Advertisement

LFCR vs SBFM

Header iconLFCR vs SBFM Comparison
Open Charts LFCR vs SBFMBanner chart's image
Lifecore Biomedical
Price$7.43
Change+$0.08 (+1.09%)
Volume$111.73K
Capitalization176.87M
Sunshine Biopharma
Price$1.57
Change+$0.02 (+1.29%)
Volume$71.74K
Capitalization6.02M
LFCR vs SBFM Comparison Chart in %
Loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFCR vs. SBFM commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Hold and SBFM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (LFCR: $7.43 vs. SBFM: $1.57)
Brand notoriety: LFCR and SBFM are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LFCR: 51% vs. SBFM: 54%
Market capitalization -- LFCR: $176.87M vs. SBFM: $6.02M
LFCR [@Pharmaceuticals: Other] is valued at $176.87M. SBFM’s [@Pharmaceuticals: Other] market capitalization is $6.02M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileSBFM’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • SBFM’s FA Score: 0 green, 5 red.
According to our system of comparison, both LFCR and SBFM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 3 TA indicator(s) are bullish while SBFM’s TA Score has 5 bullish TA indicator(s).

  • LFCR’s TA Score: 3 bullish, 4 bearish.
  • SBFM’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SBFM is a better buy in the short-term than LFCR.

Price Growth

LFCR (@Pharmaceuticals: Other) experienced а -0.80% price change this week, while SBFM (@Pharmaceuticals: Other) price change was +0.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.53%. For the same industry, the average monthly price growth was +11.98%, and the average quarterly price growth was +75.52%.

Reported Earning Dates

LFCR is expected to report earnings on Oct 02, 2025.

SBFM is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LFCR($177M) has a higher market cap than SBFM($6.02M). LFCR YTD gains are higher at: 0.000 vs. SBFM (-47.670). LFCR has higher annual earnings (EBITDA): -22.64M vs. SBFM (-26.1M). SBFM has more cash in the bank: 18.8M vs. LFCR (4.22M). SBFM has less debt than LFCR: SBFM (674K) vs LFCR (157M). LFCR has higher revenues than SBFM: LFCR (188M) vs SBFM (20.4M).
LFCRSBFMLFCR / SBFM
Capitalization177M6.02M2,942%
EBITDA-22.64M-26.1M87%
Gain YTD0.000-47.670-
P/E RatioN/A0.88-
Revenue188M20.4M922%
Total Cash4.22M18.8M22%
Total Debt157M674K23,294%
FUNDAMENTALS RATINGS
LFCR vs SBFM: Fundamental Ratings
LFCR
SBFM
OUTLOOK RATING
1..100
528
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
5264
P/E GROWTH RATING
1..100
588
SEASONALITY SCORE
1..100
5014

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBFM's Valuation (37) in the null industry is somewhat better than the same rating for LFCR (94) in the Industrial Specialties industry. This means that SBFM’s stock grew somewhat faster than LFCR’s over the last 12 months.

SBFM's Profit vs Risk Rating (100) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that SBFM’s stock grew similarly to LFCR’s over the last 12 months.

SBFM's SMR Rating (94) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that SBFM’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's Price Growth Rating (52) in the Industrial Specialties industry is in the same range as SBFM (64) in the null industry. This means that LFCR’s stock grew similarly to SBFM’s over the last 12 months.

LFCR's P/E Growth Rating (5) in the Industrial Specialties industry is significantly better than the same rating for SBFM (88) in the null industry. This means that LFCR’s stock grew significantly faster than SBFM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRSBFM
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KWGPF0.05N/A
N/A
KWG GROUP HLDGS LTD.
CNGKY9.40N/A
N/A
CK Asset Hldgs Ltd
NLIBF0.27N/A
N/A
NOA LITHIUM BRINES INC
AAUGF0.03N/A
-4.21%
AERO ENERGY LTD.
FBBPF3.50-0.18
-4.97%
FIBRA PROLOGIS REIT CTFS

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+1.09%
SHPH - LFCR
31%
Poorly correlated
+1.04%
AMRX - LFCR
28%
Poorly correlated
+0.75%
TLRY - LFCR
27%
Poorly correlated
-2.03%
ALKS - LFCR
26%
Poorly correlated
-1.51%
KMDA - LFCR
26%
Poorly correlated
-0.77%
More

SBFM and

Correlation & Price change

A.I.dvisor tells us that SBFM and TLRY have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBFM and TLRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
+1.28%
TLRY - SBFM
27%
Poorly correlated
-2.03%
ELAN - SBFM
26%
Poorly correlated
+1.57%
EBS - SBFM
25%
Poorly correlated
-4.02%
LFCR - SBFM
23%
Poorly correlated
+1.09%
CGC - SBFM
23%
Poorly correlated
+2.70%
More